• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清成纤维细胞生长因子23在血液透析患者中起什么作用?

What does serum fibroblast growth factor 23 do in hemodialysis patients?

作者信息

Emmett M

机构信息

Department of Internal Medicine, Baylor University Medical Center, 3500 Gaston Avenue, Dallas, TX 75246, USA.

出版信息

Kidney Int. 2008 Jan;73(1):3-5. doi: 10.1038/sj.ki.5002651.

DOI:10.1038/sj.ki.5002651
PMID:18084261
Abstract

Fibroblast growth factor 23 (FGF-23) is a phosphate-regulating substance largely produced by osteocytes. Its major action, in normal subjects, is the inhibition of Na-coupled reabsorption of inorganic phosphate in the renal proximal tubule. FGF-23 levels increase markedly in dialysis patients. Why do the FGF-23 levels increase in these patients, and do they have any physiologic or pathophysiologic effects?

摘要

成纤维细胞生长因子23(FGF - 23)是一种主要由骨细胞产生的磷酸盐调节物质。在正常受试者中,其主要作用是抑制肾近端小管中钠偶联的无机磷酸盐重吸收。透析患者的FGF - 23水平显著升高。为什么这些患者的FGF - 23水平会升高,以及它们是否具有任何生理或病理生理作用?

相似文献

1
What does serum fibroblast growth factor 23 do in hemodialysis patients?血清成纤维细胞生长因子23在血液透析患者中起什么作用?
Kidney Int. 2008 Jan;73(1):3-5. doi: 10.1038/sj.ki.5002651.
2
Association of circulating fibroblast growth factor-23 with renal phosphate excretion among hemodialysis patients with residual renal function.维持性血液透析患者残余肾功能与循环成纤维细胞生长因子 23 对磷排泄的影响。
Clin J Am Soc Nephrol. 2013 Jan;8(1):116-25. doi: 10.2215/CJN.00230112. Epub 2012 Oct 18.
3
FGF-23 in patients with end-stage renal disease on hemodialysis.接受血液透析的终末期肾病患者体内的成纤维细胞生长因子-23
Kidney Int. 2004 May;65(5):1943-6. doi: 10.1111/j.1523-1755.2004.00604.x.
4
[Fibroblast growth factor-23 (FGF-23). Part I. Significance in phosphate homeostasis and bone metabolism].[成纤维细胞生长因子-23(FGF-23)。第一部分。在磷酸盐稳态和骨代谢中的意义]
Przegl Lek. 2011;68(4):231-8.
5
Effect of serum FGF-23, MGP and fetuin-A on calcium-phosphate metabolism in maintenance hemodialysis patients.血清成纤维细胞生长因子-23、基质Gla蛋白和胎球蛋白-A对维持性血液透析患者钙磷代谢的影响
Hemodial Int. 2013 Oct;17(4):483-92. doi: 10.1111/hdi.12033. Epub 2013 Mar 12.
6
Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease.血清klotho:与慢性肾病患儿成纤维细胞生长因子-23及其他磷代谢调节因子的关系
Nephron. 2015;129(4):293-9. doi: 10.1159/000377633. Epub 2015 Mar 10.
7
FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.成纤维细胞生长因子-23抑制肾小管磷酸盐转运,且是磷酸盐调节内肽酶同源性X连锁基因(PHEX)的底物。
Biochem Biophys Res Commun. 2001 Jun 22;284(4):977-81. doi: 10.1006/bbrc.2001.5084.
8
Lower serum fibroblast growth factor-23 levels may suggest malnutrition in maintenance haemodialysis patients.较低的血清成纤维细胞生长因子-23水平可能提示维持性血液透析患者存在营养不良。
Nephrology (Carlton). 2014 Sep;19(9):568-73. doi: 10.1111/nep.12290.
9
[Transport of minerals in renal tubules and its hormonal regulation].
Clin Calcium. 2007 May;17(5):677-83.
10
Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.在慢性肾病患者中,随着肾功能下降,循环中FGF-23的浓度会升高,但在健康志愿者中,其浓度不会因磷摄入量的变化而改变。
Kidney Int. 2003 Dec;64(6):2272-9. doi: 10.1046/j.1523-1755.2003.00328.x.

引用本文的文献

1
FGF23 is associated with early post-transplant hypophosphataemia and normalizes faster than iPTH in living donor renal transplant recipients: a longitudinal follow-up study.成纤维细胞生长因子23与活体供肾移植受者移植后早期低磷血症相关,且其恢复正常的速度比甲状旁腺激素更快:一项纵向随访研究。
Clin Kidney J. 2016 Oct;9(5):669-76. doi: 10.1093/ckj/sfw065. Epub 2016 Jul 27.
2
Characterization of mandibular bone in a mouse model of chronic kidney disease.慢性肾脏病小鼠模型下颌骨的特征。
J Periodontol. 2010 Feb;81(2):300-9. doi: 10.1902/jop.2009.090379.
3
Management of secondary hyperparathyroidism in the elderly patient with chronic kidney disease.
老年慢性肾脏病患者继发性甲状旁腺功能亢进的管理
Drugs Aging. 2009;26(6):457-68. doi: 10.2165/00002512-200926060-00002.
4
Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions.肾脏疾病预后质量倡议组织关于骨与矿物质代谢的指南:新出现的问题
Semin Nephrol. 2009 Mar;29(2):105-12. doi: 10.1016/j.semnephrol.2009.01.003.
5
Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin.磷酸盐喂养诱导尿毒症小鼠动脉中层钙化:血清磷、成纤维细胞生长因子-23和骨桥蛋白的作用。
Kidney Int. 2009 Jun;75(12):1297-1307. doi: 10.1038/ki.2009.83. Epub 2009 Mar 25.
6
Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation.肾移植成功一年后高磷血症和肾性磷消耗的恢复情况。
Clin J Am Soc Nephrol. 2008 Nov;3(6):1829-36. doi: 10.2215/CJN.01310308. Epub 2008 Oct 15.